87.37
price up icon1.50%   1.29
after-market Dopo l'orario di chiusura: 87.25 -0.12 -0.14%
loading
Precedente Chiudi:
$86.08
Aprire:
$87.5
Volume 24 ore:
11.49M
Relative Volume:
0.84
Capitalizzazione di mercato:
$218.23B
Reddito:
$63.43B
Utile/perdita netta:
$16.42B
Rapporto P/E:
13.46
EPS:
6.49
Flusso di cassa netto:
$14.72B
1 W Prestazione:
+3.75%
1M Prestazione:
+7.06%
6M Prestazione:
-2.38%
1 anno Prestazione:
-25.04%
Intervallo 1D:
Value
$86.76
$87.83
Intervallo di 1 settimana:
Value
$84.08
$87.83
Portata 52W:
Value
$73.31
$120.30

Merck Co Inc Stock (MRK) Company Profile

Name
Nome
Merck Co Inc
Name
Telefono
908-740-4000
Name
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Name
Dipendente
75,000
Name
Cinguettio
@Merck
Name
Prossima data di guadagno
2025-02-04
Name
Ultimi documenti SEC
Name
MRK's Discussions on Twitter

Confronta MRK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.37 210.36B 63.43B 16.42B 14.72B 6.49
Drug Manufacturers - General icon
LLY
Lilly Eli Co
711.68 625.77B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
179.29 424.47B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
210.60 364.92B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
126.98 240.07B 53.40B 13.68B 16.89B 6.9231

Merck Co Inc Stock (MRK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-14 Downgrade Citigroup Buy → Neutral
2025-04-22 Iniziato Cantor Fitzgerald Neutral
2025-02-18 Downgrade Deutsche Bank Buy → Hold
2025-02-10 Downgrade TD Cowen Buy → Hold
2025-01-08 Downgrade Truist Buy → Hold
2024-12-20 Downgrade BMO Capital Markets Outperform → Market Perform
2024-12-10 Ripresa BofA Securities Buy
2024-12-04 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Peer Perform
2024-11-11 Downgrade Daiwa Securities Buy → Neutral
2024-10-17 Iniziato Bernstein Mkt Perform
2024-03-11 Downgrade Societe Generale Hold → Sell
2024-01-04 Aggiornamento TD Cowen Market Perform → Outperform
2023-11-09 Iniziato Deutsche Bank Buy
2023-10-27 Aggiornamento BMO Capital Markets Market Perform → Outperform
2023-10-20 Aggiornamento UBS Neutral → Buy
2023-07-14 Iniziato HSBC Securities Hold
2023-04-13 Aggiornamento Citigroup Neutral → Buy
2023-03-28 Downgrade Societe Generale Buy → Hold
2023-03-13 Downgrade Wells Fargo Overweight → Equal Weight
2023-03-06 Iniziato Jefferies Buy
2023-02-22 Aggiornamento Wolfe Research Peer Perform → Outperform
2023-01-04 Aggiornamento BofA Securities Neutral → Buy
2022-11-18 Iniziato Credit Suisse Outperform
2022-10-10 Aggiornamento Guggenheim Neutral → Buy
2022-09-14 Aggiornamento Berenberg Hold → Buy
2022-07-06 Aggiornamento Daiwa Securities Neutral → Buy
2022-06-06 Ripresa SVB Leerink Outperform
2022-04-06 Ripresa Morgan Stanley Equal-Weight
2021-12-17 Iniziato Goldman Buy
2021-12-16 Iniziato Daiwa Securities Neutral
2021-12-13 Downgrade UBS Buy → Neutral
2021-12-09 Iniziato Wells Fargo Overweight
2021-12-07 Downgrade Guggenheim Buy → Neutral
2021-11-29 Downgrade Citigroup Buy → Neutral
2021-11-19 Iniziato BMO Capital Markets Market Perform
2021-11-01 Aggiornamento Argus Hold → Buy
2021-09-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-07-27 Ripresa Truist Buy
2021-05-20 Downgrade Argus Buy → Hold
2021-04-07 Ripresa RBC Capital Mkts Sector Perform
2020-11-10 Ripresa Bernstein Outperform
2020-09-29 Iniziato Berenberg Hold
2020-08-03 Aggiornamento Goldman Neutral → Buy
2020-06-12 Downgrade Wolfe Research Outperform → Peer Perform
2020-02-27 Iniziato Barclays Overweight
2020-01-07 Iniziato RBC Capital Mkts Sector Perform
2019-10-17 Ripresa BofA/Merrill Neutral
2019-08-16 Iniziato SVB Leerink Outperform
2019-07-03 Iniziato Mizuho Buy
2019-05-28 Iniziato Goldman Neutral
2019-05-13 Aggiornamento Atlantic Equities Neutral → Overweight
2018-10-16 Reiterato Citigroup Buy
2018-10-09 Ripresa Guggenheim Buy
2018-04-23 Aggiornamento Goldman Neutral → Buy
2018-04-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2018-04-05 Aggiornamento Barclays Equal Weight → Overweight
2018-03-12 Aggiornamento Leerink Partners Mkt Perform → Outperform
2018-02-14 Reiterato Leerink Partners Mkt Perform
2018-02-07 Reiterato Morgan Stanley Equal-Weight
2018-01-16 Aggiornamento SunTrust Hold → Buy
Mostra tutto

Merck Co Inc Borsa (MRK) Ultime notizie

pulisher
Aug 20, 2025

Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates - GlobeNewswire Inc.

Aug 20, 2025
pulisher
Aug 19, 2025

Skyhawk’s small-molecule RNA efforts draw Merck KGaA in $2B deal - BioWorld MedTech

Aug 19, 2025
pulisher
Aug 19, 2025

Vets and Pet-Owners See Gaps in Flea and Tick Prevention, Highlighting Need for Year-Round Care, New Merck Animal Health Global Survey Finds - Business Wire

Aug 19, 2025
pulisher
Aug 18, 2025

Skyhawk Flies High With Another Big Pharma, Getting Up To $2bn In Merck KGaA Deal - insights.citeline.com

Aug 18, 2025
pulisher
Aug 18, 2025

Merck KGaA Signs $2 Billion Neurology Drug Pact With Skyhawk - Bloomberg.com

Aug 18, 2025
pulisher
Aug 18, 2025

Merck: Shares Bucking The Gardasil Problem, Hiking My Price Target - Seeking Alpha

Aug 18, 2025
pulisher
Aug 18, 2025

Q3 EPS Estimates for Merck & Co., Inc. Cut by Zacks Research - Defense World

Aug 18, 2025
pulisher
Aug 18, 2025

Janux Therapeutics Receives $10M Milestone Payment from Merck for Advancing Cancer Therapy Collaboration - MSN

Aug 18, 2025
pulisher
Aug 17, 2025

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial - MSN

Aug 17, 2025
pulisher
Aug 16, 2025

Merck Stock: Buy The Weakness (NYSE:MRK) - Seeking Alpha

Aug 16, 2025
pulisher
Aug 16, 2025

Austria Accepts Merck Commitments After ‘Predatory Pricing’ Undermined Generics - insights.citeline.com

Aug 16, 2025
pulisher
Aug 16, 2025

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey - Yahoo Finance

Aug 15, 2025
pulisher
Aug 14, 2025

Top Analyst Reports for Merck, Palo Alto & Freeport - Yahoo Finance

Aug 14, 2025
pulisher
Aug 14, 2025

10 Stocks Jim Cramer Discussed As He Questioned Official Data - Insider Monkey

Aug 14, 2025
pulisher
Aug 13, 2025

Livestock Monitoring Company Evaluation Report 2025 | Merck & Co., GEA Group, and DeLaval Drive Global Innovations Across Biopharma, Process Technology, and Dairy Farming Automation - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Stock Watch: Sanofi And Merck Temper Big Pharma Q2 Earnings Cheer - insights.citeline.com

Aug 13, 2025
pulisher
Aug 12, 2025

Goldman Sachs Slashes PT on Merck & Co. (MRK) to $94 From $99, Keeps a Buy Rating - MSN

Aug 12, 2025
pulisher
Aug 12, 2025

What's Going On With Merck Stock Tuesday?Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE) - Benzinga

Aug 12, 2025
pulisher
Aug 12, 2025

IO Biotech's cancer vaccine shows improvement, but narrowly misses study goal - Reuters

Aug 12, 2025
pulisher
Aug 11, 2025

Merck to Begin Phase 3 Trials for Investigational Monthly HIV Prevention Pill - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Merck KGaA Plans $4 Billion Bond Sale to Fund SpringWorks Therapeutics Acquisition - Bloomberg.com

Aug 11, 2025
pulisher
Aug 10, 2025

Merck & Co Stock Ends Higher After Volatile Session - thekhabrilal

Aug 10, 2025
pulisher
Aug 10, 2025

Analysts Set Merck & Co., Inc. (NYSE:MRK) Price Target at $107.44 - Defense World

Aug 10, 2025
pulisher
Aug 10, 2025

Critical Review: Merck & Co., Inc. (NYSE:MRK) and Johnson & Johnson (NYSE:JNJ) - Defense World

Aug 10, 2025
pulisher
Aug 09, 2025

The departure of senior executives from Merck & Co Inc and Novartis triggered a "chain reaction". Heng Rui and Wise had intensive personnel changes in local pharmaceutical companies. Inventory of personnel changes in October. - 富途牛牛

Aug 09, 2025
pulisher
Aug 09, 2025

Merck & Co. (MRK) Divests Surface Solutions for €665 million - MSN

Aug 09, 2025
pulisher
Aug 08, 2025

Goldman Sachs Reduced the PT on Merck & Co., Inc. (MRK), Kept a Buy Rating - MSN

Aug 08, 2025
pulisher
Aug 07, 2025

Verona’s COPD Launch Success Sealed Merck Buyout Interest - insights.citeline.com

Aug 07, 2025
pulisher
Aug 07, 2025

Merck & Co Inc Options Trading: September 26th Expiration - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda - Yahoo Finance

Aug 07, 2025
pulisher
Aug 06, 2025

Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline - MSN

Aug 06, 2025
pulisher
Aug 04, 2025

UBS Bullish on Merck (MRK) Following Verona Pharma Purchase - MSN

Aug 04, 2025
pulisher
Aug 04, 2025

Palmetto Grain Brokerage - Palmetto Grain Brokerage

Aug 04, 2025
pulisher
Aug 03, 2025

11 Cheap Pharmaceutical Stocks to Buy Now - Insider Monkey

Aug 03, 2025

Merck Co Inc Azioni (MRK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general NVO
$56.98
price up icon 2.76%
drug_manufacturers_general NVS
$126.98
price up icon 0.13%
$293.72
price down icon 0.69%
drug_manufacturers_general PFE
$25.88
price up icon 0.54%
$114.77
price down icon 1.19%
Capitalizzazione:     |  Volume (24 ore):